{"id":1190,"date":"2020-08-26T09:33:21","date_gmt":"2020-08-26T09:33:21","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/siemens-healthineers-to-build-diagnostics-manufacturing-facility-in-china\/"},"modified":"2021-01-08T11:09:59","modified_gmt":"2021-01-08T11:09:59","slug":"siemens-healthineers-to-build-diagnostics-manufacturing-facility-in-china","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/siemens-healthineers-to-build-diagnostics-manufacturing-facility-in-china\/","title":{"rendered":"Siemens Healthineers to build diagnostics manufacturing facility in China"},"content":{"rendered":"<p>Siemens Healthineers will expand the company\u2019s existing manufacturing operations in Shanghai, China to include a new in vitro diagnostics facility. The China manufacturing facility will enable in-country manufacturing capabilities for clinical chemistry and immunoassay reagents. \u201cThis investment demonstrates the company\u2019s continued commitment to address the evolving needs in the Chinese market and in healthcare markets across the globe,\u201d said Franz Walt, President, Laboratory Diagnostics, Siemens Healthineers. China is the second largest market for Siemens Healthineers. According to George Chan, President, Greater China, Siemens Healthineers, \u201cThe opening of this facility strengthens our ability to support Chinese healthcare reform as we deliver better outcomes at a lower cost to our customers.\u201d The company expects to employ hundreds of additional employees once the project is completed.<\/p>\n<p><link http:\/\/www.healthcare.siemens.com _blank external-link-new-window>www.healthcare.siemens.com<\/link>\n","protected":false},"excerpt":{"rendered":"<p>Siemens Healthineers will expand the company\u2019s existing manufacturing operations in Shanghai, China to include a new in vitro diagnostics facility. The China manufacturing facility will enable in-country manufacturing capabilities for clinical chemistry and immunoassay reagents. \u201cThis investment demonstrates the company\u2019s continued commitment to address the evolving needs in the Chinese market and in healthcare markets [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[35],"tags":[],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/1190"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=1190"}],"version-history":[{"count":0,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/1190\/revisions"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=1190"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=1190"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=1190"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}